You are here

Eric Williams

  • Managing Director
215-854-4065
(add to contacts)

Biography

Based out of Philadelphia, Eric serves as a Managing Director at Capstone Headwaters and leads Capstone’s Health and Medical practice. Eric has successfully completed more than 100 transactions in sectors including contract manufacturing, pharmaceutical outsourcing, medical devices, and life sciences, and health care services. Prior to Capstone, Eric was responsible for managing the Eastern region for Morgan Stanley Smith Barney’s Capital Strategies Group and its predecessor, Citi Capital Strategies.  Eric has 20 years of experience managing strategic sale assignments and leveraged recapitalizations for owners of privately held companies.

He has also executed complex cross-border transactions with foreign buyers based in London, Germany, Sweden and Switzerland and has structured deals with leading private equity groups and strategic corporate buyers.  Previously, Mr. Williams worked as a senior executive with Newport Securities Corporation.

Education

The University of California - BS - Economics

Registrations & Affiliations

FINRA - Series 24 General Securities Principal

FINRA - Series 7 & 63 Registered General Securities Representative

Industry Coverage

While COVID-19 has severely hampered sales for medical device original equipment manufacturers (OEMs), the resumption of elective surgeries has begun to restore demand for devices and instruments.  Merger and acquisition activity in the Medical Device Outsourcing industry has stalled through the first half of 2020, with 19 transactions announced or completed year-to-date (YTD) compared to 46 deals in YTD 2019.Read more

The pandemic has emphasized the need for the industry to rethink its reliance on offshore manufacturing and complex global supply chains, as well as how to utilize technology to adopt a more decentralized approach to conducting clinical trials.  While COVID-19 has certainly challenged contract research organizations (CROs) in administration of on-site activities and clinical trials, it has also fostered heightened innovation and implementation of remote technology.  Virtual trials and eClinical solutions have gained increased adoption as CROs seek creative options for decentralized management of clinical trials.Read more

Merger and acquisition (M&A) activity has slowed substantially in year-to-date (YTD) 2020 with seven transactions announced or completed compared to 25 transactions in YTD 2019.  However, as Q2 closes, the substantial amount of private equity dry powder presents a favorable backdrop for deal activity to rebound in the Healthcare Staffing industry.Read more